Corcept Therapeutics Incorporated shares owned by Morgan Stanley
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Corcept Therapeutics Incorporated by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $119M | 1.6M | 73.40 |
| 2024-12-31 | $64M | 1.3M | 50.39 |
| 2024-09-30 | $68M | 1.5M | 46.28 |
| 2024-06-30 | $43M | 1.3M | 32.49 |
| 2024-03-31 | $38M | 1.5M | 25.19 |
| 2023-12-31 | $42M | 1.3M | 32.48 |
| 2023-09-30 | $33M | 1.2M | 27.24 |
| 2023-06-30 | $21M | 929k | 22.25 |
| 2022-12-31 | $22M | 1.1M | 20.32 |
| 2022-06-30 | $23M | 967k | 23.55 |
| 2022-03-31 | $19M | 825k | 22.52 |
| 2021-06-30 | $13M | 604k | 21.99 |
| 2020-12-31 | $11M | 417k | 26.16 |
| 2020-09-30 | $7.3M | 421k | 17.41 |
| 2020-06-30 | $6.9M | 411k | 16.82 |
| 2020-03-31 | $9.9M | 836k | 11.89 |
| 2019-12-31 | $14M | 1.2M | 12.10 |
| 2019-09-30 | $14M | 1.0M | 14.13 |
| 2019-03-31 | $12M | 1.0M | 11.75 |
| 2018-12-31 | $20M | 1.5M | 13.36 |
| 2018-09-30 | $26M | 1.8M | 14.02 |
| 2018-06-30 | $18M | 1.1M | 15.72 |
| 2018-03-31 | $13M | 783k | 16.45 |
| 2017-12-31 | $6.2M | 344k | 18.06 |
| 2017-03-31 | $14M | 1.3M | 10.96 |
| 2016-12-31 | $12M | 1.6M | 7.26 |
| 2016-09-30 | $9.7M | 1.5M | 6.50 |
| 2016-06-30 | $11M | 2.1M | 5.47 |
| 2016-03-31 | $8.9M | 2.1M | 4.24 |
| 2015-12-31 | $10M | 2.1M | 4.97 |
| 2015-09-30 | $8.1M | 2.2M | 3.76 |
| 2015-06-30 | $11M | 1.8M | 6.00 |
| 2014-12-31 | $0 | 1.5M | 0.00 |
| 2014-09-30 | $3.9M | 1.5M | 2.65 |
| 2014-06-30 | $4.2M | 1.5M | 2.80 |
| 2014-03-31 | $6.5M | 1.5M | 4.36 |
| 2013-12-31 | $759k | 237k | 3.20 |
| 2013-09-30 | $298k | 180k | 1.65 |
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated